GO:0001920 negative regulation of receptor recycling: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001920 (negative regulation of receptor recycling) describes any process that stops, prevents, or reduces the rate at which receptors return to the plasma membrane after endocytosis.
• This regulatory step is essential for controlling receptor abundance at the cell surface and for tuning downstream signaling, nutrient uptake, and immune responses [1,3,5].
• Key molecular players include TLR4, CD14, Trem2, CD36, CTLA-4, LRBA, Rab11, Numb, Notch1, CD51, ST3GAL1, and βII-spectrin [1,3,5,6,7].
• Dysregulated negative regulation of receptor recycling contributes to inflammatory signaling, cancer stemness, immune evasion, and altered iron homeostasis [1,2,3,4,6].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of receptor recycling control [4,6].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study negative regulation of receptor recycling in disease contexts [4,6].
Description
Receptor recycling is the process by which internalized receptors are returned from endosomal compartments to the plasma membrane, allowing cells to reuse receptors rather than degrade them [1,5]. Negative regulation of receptor recycling (GO:0001920) refers to any process that stops, prevents, or reduces the rate of this recycling step. This regulatory mechanism is critical because it determines how many receptors remain at the cell surface and how long signaling persists after ligand stimulation [1,5]. For example, TLR4 and CD14 trafficking is tightly controlled to prevent excessive pro-inflammatory signaling in response to LPS. Similarly, CTLA-4 recycling is regulated by LRBA and Rab11, which influences immune checkpoint function. In the brain, soluble Trem2 negatively regulates erythrophagocytosis by modulating CD36 receptor recycling after intracerebral hemorrhage. These examples illustrate that negative regulation of receptor recycling is not a passive process but an actively controlled node that shapes cell physiology and disease [1,3,5]. Researchers studying this term need to understand its molecular players, regulatory inputs, and experimental approaches to manipulate it precisely [4,6].
negative regulation of receptor recycling At A Glance
| GO ID | GO:0001920 |
|---|---|
| GO term | negative regulation of receptor recycling |
| Ontology | biological_process |
| Synonym | down regulation of receptor recycling; down-regulation of receptor recycling; downregulation of receptor recycling; inhibition of receptor recycling |
| Major function | Reduces the rate of receptor return to the plasma membrane, thereby controlling surface receptor abundance and downstream signaling [1,5] |
| Related processes | Endosomal sorting, receptor degradation, signal attenuation, immune regulation [1,3,5] |
| Key regulators | TLR4, CD14, Trem2, CD36, CTLA-4, LRBA, Rab11, Numb, Notch1, CD51, ST3GAL1, βII-spectrin [1,3,5,6,7] |
| Disease relevance | Inflammation, cancer stemness, immune evasion, iron homeostasis, neurodegeneration [1,2,3,4,6] |
What Is GO:0001920?
According to the Gene Ontology, GO:0001920 (negative regulation of receptor recycling) is defined as any process that stops, prevents, or reduces the rate of receptor recycling. In other words, it is a biological brake on the return of internalized receptors to the plasma membrane, leading to reduced surface receptor levels or delayed receptor reutilization [1,5].
Why Is negative regulation of receptor recycling Important in Cell Biology?
Negative regulation of receptor recycling is important because it sets the threshold for receptor-mediated signaling and nutrient uptake [1,4]. When this brake fails, receptors can recycle excessively, leading to prolonged or amplified signaling that contributes to inflammation, cancer progression, and immune dysfunction [1,4,6]. Conversely, excessive negative regulation can reduce receptor availability and impair normal cellular responses [3,5]. Understanding GO:0001920 therefore provides mechanistic insight into how cells balance receptor reuse versus degradation, and it offers therapeutic opportunities to modulate receptor-dependent pathways in disease [1,3,5].
• Controls cell surface receptor levels and signaling duration [1,5].
• Prevents excessive pro-inflammatory signaling by limiting TLR4 and CD14 recycling.
• Regulates immune checkpoint function through CTLA-4 recycling control.
• Modulates erythrophagocytosis via CD36 receptor recycling in the brain.
• Influences cancer stemness by affecting Numb-mediated Notch1 degradation.
• Impacts nutrient acquisition through macropinocytosis and receptor trafficking.
• Contributes to systemic iron homeostasis via receptor recycling regulation.
• Provides targets for therapeutic intervention in inflammation and cancer [1,4,6].
• Enables precise experimental dissection using CRISPR models [4,6].
• Links endosomal trafficking to cell fate decisions and immune responses [3,5,7].
What Happens During negative regulation of receptor recycling?
Initiation of negative regulation
In simple terms: A signal tells the cell to slow down the return of receptors to the surface.
Negative regulation of receptor recycling begins when specific molecular cues, such as ligand binding or intracellular signaling events, trigger pathways that inhibit the recycling machinery [1,5]. For instance, TLR4 and CD14 trafficking is influenced by LPS-induced signaling that can alter their recycling rates. Similarly, CTLA-4 recycling is regulated by LRBA and Rab11, where changes in these regulators can reduce recycling.
Retention in endosomal compartments
In simple terms: Receptors are held inside the cell instead of being sent back to the surface.
Once negative regulation is initiated, receptors are retained in endosomal compartments, preventing their return to the plasma membrane [1,3]. This retention can involve altered interactions with Rab proteins or sorting nexins that normally promote recycling. For example, soluble Trem2 negatively regulates erythrophagocytosis by modulating CD36 receptor recycling, likely by retaining CD36 intracellularly.
Sorting to degradation or storage
In simple terms: Held receptors may be sent for destruction or stored for later use.
Retained receptors can be sorted to lysosomes for degradation or stored in intracellular pools [1,4]. This sorting decision is influenced by ubiquitination and endosomal sorting complexes. In cancer cells, macropinocytosis and receptor trafficking are reprogrammed to support nutrient acquisition, and negative regulation of recycling can shift receptors toward degradation.
Downstream signaling consequences
In simple terms: Less receptor on the surface means weaker or shorter signals.
By reducing receptor recycling, cells limit the amount of receptor available for ligand binding at the plasma membrane, thereby attenuating downstream signaling [1,5]. This is critical for preventing excessive inflammatory responses, as seen with TLR4 and CD14. In T cells, regulation of CTLA-4 recycling affects immune checkpoint activity.
Feedback and reversal
In simple terms: The brake can be released when conditions change.
Negative regulation of receptor recycling is often reversible, allowing cells to restore recycling when needed [1,5]. Feedback mechanisms involving Rab11 and LRBA can modulate CTLA-4 recycling. In iron homeostasis, receptor recycling is adjusted to meet metabolic demands.
Key Genes Involved in GO:0001920 negative regulation of receptor recycling
The following genes and proteins are experimentally implicated in negative regulation of receptor recycling or related trafficking pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | Innate immune receptor; its trafficking and recycling influence LPS-induced signaling | Target for studying inflammation and receptor recycling control |
| CD14 | Co-receptor for LPS; trafficking affects TLR4 signaling | Model to dissect negative regulation of receptor recycling in immunity |
| Trem2 | Soluble form negatively regulates erythrophagocytosis via CD36 recycling | Neuroinflammation and hemorrhage research |
| CD36 | Scavenger receptor; recycling modulated by Trem2 | Study of phagocytosis and lipid metabolism |
| CTLA-4 | Immune checkpoint; recycling regulated by LRBA and Rab11 | Cancer immunotherapy and autoimmunity research |
| LRBA | Regulates CTLA-4 recycling | Immune dysregulation studies |
| Rab11 | Small GTPase controlling recycling endosome traffic | General recycling machinery research |
| Numb | Regulates Notch1 degradation; linked to CD51 in cancer stemness | Cancer stem cell biology |
| Notch1 | Receptor whose degradation is affected by Numb | Developmental and cancer signaling |
| CD51 | Promotes gastric cancer stemness by blocking Numb-mediated Notch1 degradation | Gastric cancer research |
| ST3GAL1 | Sialyltransferase affecting CAR T cell migration | Immunotherapy trafficking studies |
| βII-spectrin | Cytoskeletal protein involved in CAR T cell migration | Cell migration and cytoskeleton research |
| Transferrin receptor | Mediates iron uptake; recycling is regulated in iron homeostasis | Iron metabolism studies |
| Ferroportin | Iron exporter; its regulation relates to systemic iron homeostasis | Iron homeostasis research |
| Hepcidin | Regulates iron homeostasis; affects receptor recycling indirectly | Systemic iron regulation |
| Macropinocytosis regulators | Control nutrient acquisition and receptor trafficking in cancer | Cancer metabolism research |
| Endosomal sorting complexes | Sort receptors for recycling or degradation | Basic trafficking mechanisms |
| Rab family GTPases | Regulate endosomal recycling | Broad cell biology research |
How Is negative regulation of receptor recycling Regulated?
Negative regulation of receptor recycling is controlled by a network of signaling molecules and trafficking regulators [1,5]. Rab11 and LRBA directly modulate CTLA-4 recycling, and their activity can be influenced by immune signals. TLR4 and CD14 trafficking is regulated by LPS-induced signaling pathways that alter recycling rates. In iron homeostasis, systemic signals adjust receptor recycling to maintain iron balance. Additionally, cancer cells can reprogram macropinocytosis and receptor trafficking to support growth, indicating that oncogenic pathways impinge on this process.
negative regulation of receptor recycling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR4 | Inflammation, sepsis | Knockout macrophages, LPS stimulation |
| CTLA-4 | Autoimmunity, cancer immunotherapy | Knockout T cells, recycling assays |
| CD51 | Gastric cancer stemness | Knockout gastric cancer cell lines |
| Trem2 | Intracerebral hemorrhage, neuroinflammation | Knockout microglia, hemorrhage models |
| Transferrin receptor | Iron homeostasis disorders | Knockout hepatocytes, iron flux assays |
Inflammation and immune dysregulation
Negative regulation of receptor recycling is critical for limiting inflammatory responses. TLR4 and CD14 trafficking influences LPS-induced pro-inflammatory signaling, and dysregulated recycling can lead to excessive inflammation. CTLA-4 recycling, regulated by LRBA and Rab11, is essential for immune checkpoint function, and its disruption is linked to immune dysregulation.
Cancer progression and stemness
In cancer, altered receptor recycling can promote stemness and nutrient acquisition. CD51 promotes gastric cancer stemness by blocking Numb-mediated Notch1 degradation, a process tied to receptor trafficking. Macropinocytosis and receptor recycling support metabolic reprogramming in cancer cells, offering therapeutic targets.
Neurodegeneration and brain hemorrhage
Soluble Trem2 negatively regulates erythrophagocytosis after intracerebral hemorrhage by modulating CD36 receptor recycling. This highlights how negative regulation of receptor recycling affects brain injury and neuroinflammation.
Iron homeostasis disorders
Systemic iron homeostasis depends on regulated receptor recycling, including transferrin receptor and ferroportin. Disruption of these processes can contribute to iron overload or deficiency disorders.
From negative regulation of receptor recycling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate receptor recycling? | CRISPR knockout cell line [4,6] |
| Does a specific mutation alter recycling control? | Point-mutation knock-in [4,6] |
| How does tagging affect receptor trafficking? | Tagged knock-in [4,6] |
| Does overexpression enhance negative regulation? | Overexpression cell model [4,6] |
| Which genes modulate receptor recycling in a disease context? | CRISPR library screening [4,6] |
| What are the transcriptomic consequences? | RNA-seq after knockout [4,6] |
How to Study the negative regulation of receptor recycling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Antibody-feeding assay | Rate of receptor recycling to surface | Quantify negative regulation |
| Flow cytometry | Surface receptor levels [1,5] | Assess recycling changes [1,5] |
| Live-cell imaging | Receptor trafficking dynamics [1,3] | Visualize retention [1,3] |
| RNA-seq | Transcriptomic changes [4,6] | Identify downstream pathways [4,6] |
| Proteomics | Protein abundance and interactions [4,6] | Discover regulators [4,6] |
| CRISPR knockout | Loss-of-function effects [4,6] | Test causality [4,6] |
| CRISPR knock-in | Tagged or mutant receptor behavior [4,6] | Track endogenous receptors [4,6] |
| CRISPR library screening | Genome-wide modifiers [4,6] | Identify novel regulators [4,6] |
Receptor recycling assays
Receptor recycling can be measured using antibody-feeding assays, flow cytometry, and fluorescent imaging to track internalized receptors returning to the surface [1,5]. These methods are essential to quantify negative regulation [1,5].
CRISPR-based perturbation
CRISPR knockout, point mutation, knock-in, and overexpression enable precise manipulation of genes involved in receptor recycling [4,6]. These approaches allow causal testing of candidate regulators [4,6].
Transcriptomics and proteomics
RNA-seq and proteomics can reveal global changes in gene expression and protein abundance after perturbing negative regulation of receptor recycling [4,6]. These methods identify downstream pathways and biomarkers [4,6].
Imaging and trafficking analysis
Live-cell imaging and colocalization studies with endosomal markers visualize receptor trafficking and retention [1,3]. These techniques are critical for understanding the spatial dynamics of negative regulation [1,3].
How CRISPR Can Be Used to Study GO:0001920 negative regulation of receptor recycling
Knockout
CRISPR knockout of candidate genes such as TLR4, CTLA-4, or CD51 can reveal whether they are required for negative regulation of receptor recycling [1,5,6]. Knockout models are ideal for loss-of-function studies [4,6].
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to disrupt specific phosphorylation sites in recycling regulators [4,6]. This allows fine mapping of functional domains [4,6].
Knock-in
Knock-in of fluorescent or affinity tags enables tracking of endogenous receptors and regulators in real time [4,6]. Tagged knock-in models are valuable for imaging recycling dynamics [4,6].
Overexpression
Overexpression of genes like Trem2 or LRBA can enhance negative regulation of receptor recycling and test sufficiency [3,5]. Overexpression models complement knockout studies [4,6].
How EDITGENE Supports negative regulation of receptor recycling Research
Researchers studying negative regulation of receptor recycling-related genes often need to determine whether a candidate gene is causally involved in controlling receptor trafficking, signaling, or disease phenotypes. EDITGENE provides validated CRISPR cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of receptor recycling research.
Frequently Asked Questions About negative regulation of receptor recycling
What is negative regulation of receptor recycling?
It is any process that stops, prevents, or reduces the rate of receptor recycling, defined as GO:0001920.
What genes are involved in negative regulation of receptor recycling?
Key genes include TLR4, CD14, Trem2, CD36, CTLA-4, LRBA, Rab11, Numb, Notch1, CD51, ST3GAL1, and βII-spectrin [1,3,5,6,7].
How does negative regulation of receptor recycling affect inflammation?
It limits TLR4 and CD14 recycling, thereby attenuating LPS-induced pro-inflammatory signaling.
What is the role of CTLA-4 recycling in immune regulation?
CTLA-4 recycling is regulated by LRBA and Rab11, and its control is important for immune checkpoint function.
How is CD36 receptor recycling regulated in the brain?
Soluble Trem2 negatively regulates erythrophagocytosis after intracerebral hemorrhage by modulating CD36 receptor recycling.
Can CRISPR be used to study negative regulation of receptor recycling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of this process [4,6].
What diseases are linked to defective receptor recycling?
Inflammation, cancer stemness, immune dysregulation, neurodegeneration, and iron homeostasis disorders [1,2,3,4,5,6].
What methods measure receptor recycling?
Antibody-feeding assays, flow cytometry, live-cell imaging, RNA-seq, and proteomics [1,3,4,5,6].
What is the GO ID for negative regulation of receptor recycling?
GO:0001920.
How can EDITGENE help study negative regulation of receptor recycling?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services [4,6].
Conclusion
Negative regulation of receptor recycling (GO:0001920) is a fundamental biological process that controls receptor abundance at the cell surface and shapes signaling outcomes in health and disease [1,5]. Its molecular players, including TLR4, CTLA-4, Trem2, and CD51, are implicated in inflammation, cancer, and neurodegeneration [1,3,5,6]. By leveraging CRISPR-based models and advanced screening, researchers can uncover new therapeutic targets and mechanisms [4,6]. EDITGENE offers comprehensive services to support these discoveries.
References
- 1. Ciesielska A et al.. 2021. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.. Cell Mol Life Sci 78(4):1233-1261 PMID: 33057840
- 2. Ganz T. 2013. Systemic iron homeostasis.. Physiol Rev 93(4):1721-41 PMID: 24137020
- 3. Zhou H et al.. 2023. Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner.. J Adv Res 44:185-199 PMID: 36725189
- 4. Xu G et al.. 2025. Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting.. Autophagy 21(4):693-718 PMID: 39817564
- 5. Janman D et al.. 2021. Regulation of CTLA-4 recycling by LRBA and Rab11.. Immunology 164(1):106-119 PMID: 33960403
- 6. Peng J et al.. 2025. CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation.. Cancer Lett 629:217886 PMID: 40555320
- 7. Hong Y et al.. 2023. ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors.. Nat Immunol 24(6):1007-1019 PMID: 37069398
